Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 307

1.

Magnetic resonance enterography predicts the prognosis of Crohn's disease.

Lee JH, Park YE, Seo N, Lee HJ, Park SJ, Kim TI, Kim WH, Lim JS, Cheon JH.

Intest Res. 2018 Jul;16(3):445-457. doi: 10.5217/ir.2018.16.3.445. Epub 2018 Jul 27.

2.

Association of Perianal Fistulas with Clinical Features and Prognosis of Crohn's Disease in Korea: Results from the CONNECT Study.

Chun J, Im JP, Kim JW, Lee KL, Choi CH, Kim H, Cheon JH, Ye BD, Kim YH, Kim YS, Jeen YT, Han DS, Kim WH, Kim JS.

Gut Liver. 2018 Jul 20. doi: 10.5009/gnl18157. [Epub ahead of print]

3.

Does Medical Acceleration Improve Outcomes in Ulcerative Colitis Patients Who Are in Clinical Remission but Have Endoscopic Inflammation?

Chang JY, Cheon JH, Park Y, Park SJ, Kim TI, Kim WH.

Dig Dis Sci. 2018 Jul 9. doi: 10.1007/s10620-018-5193-2. [Epub ahead of print]

PMID:
29987626
4.

Risk factors and clinical courses of concomitant primary sclerosing cholangitis and ulcerative colitis: a Korean multicenter study.

Park YE, Cheon JH, Park JJ, Kim YJ, Choi CH, Park Y, Park SJ, Kim TI, Kim WH.

Int J Colorectal Dis. 2018 Jul 9. doi: 10.1007/s00384-018-3123-6. [Epub ahead of print]

PMID:
29987360
5.

Development of a Novel Endoscopic Scoring System to Predict Relapse after Surgery in Intestinal Behçet's Disease.

Park JW, Park Y, Park SJ, Kim TI, Kim WH, Cheon JH.

Gut Liver. 2018 Jun 22. doi: 10.5009/gnl17547. [Epub ahead of print]

6.

Lactobacillus acidophilus suppresses intestinal inflammation by inhibiting endoplasmic reticulum stress.

Kim DH, Kim S, Lee JH, Kim JH, Che X, Ma HW, Seo DH, Kim TI, Kim WH, Kim SW, Cheon JH.

J Gastroenterol Hepatol. 2018 Jun 22. doi: 10.1111/jgh.14362. [Epub ahead of print]

PMID:
29933526
7.

Anti-Tumor Necrosis Factor Therapy in Intestinal Behçet's Disease.

Park J, Cheon JH.

Gut Liver. 2018 May 24. doi: 10.5009/gnl17462. [Epub ahead of print] Review.

8.

Efficacy and tolerability of methotrexate therapy for refractory intestinal Behçet's disease: a single center experience.

Park J, Cheon JH, Park Y, Park SJ, Kim TI, Kim WH.

Intest Res. 2018 Apr;16(2):315-318. doi: 10.5217/ir.2018.16.2.315. Epub 2018 Apr 30. No abstract available.

9.

Deep Resequencing of Ulcerative Colitis-Associated Genes Identifies Novel Variants in Candidate Genes in the Korean Population.

Moon CM, Kim SW, Ahn JB, Ma HW, Che X, Kim TI, Kim WH, Cheon JH.

Inflamm Bowel Dis. 2018 Jul 12;24(8):1706-1717. doi: 10.1093/ibd/izy122.

PMID:
29733354
10.

Long-Term Outcomes of Endoscopic Balloon Dilation for Benign Strictures in Patients with Inflammatory Bowel Disease.

Lee HW, Park SJ, Jeon SR, Ye BD, Park JJ, Cheon JH, Kim TI, Kim WH; Korean Association for the Study of the Intestinal Diseases (KASID) study.

Gut Liver. 2018 Jun 22. doi: 10.5009/gnl17396. [Epub ahead of print]

11.

Postoperative course of Crohn disease according to timing of bowel resection: Results from the CONNECT Study.

Lee JM, Lee KM, Kim JS, Kim YS, Cheon JH, Ye BD, Kim YH, Han DS, Lee CK, Park HJ.

Medicine (Baltimore). 2018 Apr;97(16):e0459. doi: 10.1097/MD.0000000000010459.

12.

Comparison of Concomitant Mesalamine and Immunomodulator Therapy and Immunomodulator Monotherapy for Crohn's Disease.

Kwak MS, Kim KJ, Cheon JH, Kim WS, Lee JM, Hwang SW, Park SH, Yang DH, Ye BD, Byeon JS, Myung SJ, Yang SK.

Gastroenterol Res Pract. 2018 Jan 18;2018:4826973. doi: 10.1155/2018/4826973. eCollection 2018.

13.

The Efficacy and Safety of Acupuncture for the Treatment of Children with Autism Spectrum Disorder: A Systematic Review and Meta-Analysis.

Lee B, Lee J, Cheon JH, Sung HK, Cho SH, Chang GT.

Evid Based Complement Alternat Med. 2018 Jan 11;2018:1057539. doi: 10.1155/2018/1057539. eCollection 2018. Review.

14.

Protective effects of guggulsterone against colitis are associated with the suppression of TREM-1 and modulation of macrophages.

Che X, Park KC, Park SJ, Kang YH, Jin HA, Kim JW, Seo DH, Kim DK, Kim TI, Kim WH, Kim SW, Cheon JH.

Am J Physiol Gastrointest Liver Physiol. 2018 Jul 1;315(1):G128-G139. doi: 10.1152/ajpgi.00027.2018. Epub 2018 Mar 15.

PMID:
29543509
15.

Long-term outcomes after stenting as a bridge to surgery in patients with obstructing left-sided colorectal cancer.

Park J, Lee HJ, Park SJ, Hur H, Min BS, Cheon JH, Kim TI, Kim NK, Kim WH.

Int J Colorectal Dis. 2018 Jun;33(6):799-807. doi: 10.1007/s00384-018-3009-7. Epub 2018 Mar 12.

PMID:
29532209
16.

Resting heart rate is an independent predictor of advanced colorectal adenoma recurrence.

Park J, Kim JH, Park Y, Park SJ, Cheon JH, Kim WH, Park JS, Jeon JY, Kim TI.

PLoS One. 2018 Mar 2;13(3):e0193753. doi: 10.1371/journal.pone.0193753. eCollection 2018.

17.

The Natural Compound Dansameum Reduces foam Cell Formation by Downregulating CD36 and Peroxisome Proliferator-activated Receptor-gamma; Expression.

Park KS, Ahn SH, Lee KP, Park SY, Cheon JH, Choi JY, Kim K.

Pharmacogn Mag. 2018 Jan;13(Suppl 4):S868-S874. doi: 10.4103/pm.pm_112_17. Epub 2018 Jan 31.

18.
19.

Clinical outcomes and factors related to colonic perforations in patients receiving self-expandable metal stent insertion for malignant colorectal obstruction.

Lee YJ, Yoon JY, Park JJ, Park SJ, Kim JH, Youn YH, Kim TI, Park H, Kim WH, Cheon JH.

Gastrointest Endosc. 2018 Jun;87(6):1548-1557.e1. doi: 10.1016/j.gie.2018.02.006. Epub 2018 Feb 13.

PMID:
29452077
20.

Cancer Risk in Patients with Intestinal Behçet's Disease: A Nationwide Population-Based Study.

Han M, Jung YS, Kim WH, Cheon JH, Park S.

Gut Liver. 2018 Jul 15;12(4):433-439. doi: 10.5009/gnl17324.

21.

Effects of metformin on colorectal cancer stem cells depend on alterations in glutamine metabolism.

Kim JH, Lee KJ, Seo Y, Kwon JH, Yoon JP, Kang JY, Lee HJ, Park SJ, Hong SP, Cheon JH, Kim WH, Ii Kim T.

Sci Rep. 2018 Jan 11;8(1):409. doi: 10.1038/s41598-017-18762-4.

22.

Cancer risk in Korean patients with Behçet's disease: A nationwide population-based study.

Jung YS, Han M, Kim DY, Cheon JH, Park S.

PLoS One. 2017 Dec 29;12(12):e0190182. doi: 10.1371/journal.pone.0190182. eCollection 2017.

23.

Impact and outcomes of nutritional support team intervention in patients with gastrointestinal disease in the intensive care unit.

Park YE, Park SJ, Park Y, Cheon JH, Kim TI, Kim WH.

Medicine (Baltimore). 2017 Dec;96(49):e8776. doi: 10.1097/MD.0000000000008776.

24.

Clinical Outcomes of Self-Expandable Metal Stents for Malignant Rectal Obstruction.

Lee HJ, Hong SP, Cheon JH, Kim TI, Kim WH, Park SJ.

Dis Colon Rectum. 2018 Jan;61(1):43-50. doi: 10.1097/DCR.0000000000000910.

PMID:
29215476
25.

Updated treatment strategies for intestinal Behçet's disease.

Park YE, Cheon JH.

Korean J Intern Med. 2018 Jan;33(1):1-19. doi: 10.3904/kjim.2017.377. Epub 2017 Dec 8. Review.

26.
27.

Risk Factors and Outcomes of Emergency Room Visits in Intestinal Behçet's Disease.

Park J, Cheon JH, Park Y, Park SJ, Kim TI, Kim WH.

Digestion. 2017 Nov 2;96(4):231-238. doi: 10.1159/000484084. [Epub ahead of print]

PMID:
29131059
28.

The outcomes and risk factors of early readmission in patients with intestinal Behçet's disease.

Park YE, Cheon JH, Park Y, Park SJ, Kim TI, Kim WH.

Clin Rheumatol. 2018 Jul;37(7):1913-1920. doi: 10.1007/s10067-017-3904-2. Epub 2017 Nov 7.

PMID:
29116542
29.

Effects of Perianal Involvement on Clinical Outcomes in Crohn's Disease over 10 Years.

Yoon JY, Cheon JH, Park SJ, Kim TI, Kim WH.

Gut Liver. 2018 May 15;12(3):297-305. doi: 10.5009/gnl17275.

30.

Comparison of Colonoscopy Surveillance Outcomes Between Young and Older Colorectal Cancer Patients.

Kim SB, Lee HJ, Park SJ, Hong SP, Cheon JH, Kim WH, Kim TI.

J Cancer Prev. 2017 Sep;22(3):159-165. doi: 10.15430/JCP.2017.22.3.159. Epub 2017 Sep 30.

31.

Sex-dependent difference in the effect of metformin on colorectal cancer-specific mortality of diabetic colorectal cancer patients.

Park JW, Lee JH, Park YH, Park SJ, Cheon JH, Kim WH, Kim TI.

World J Gastroenterol. 2017 Jul 28;23(28):5196-5205. doi: 10.3748/wjg.v23.i28.5196.

32.

The Clinical Characteristics and Prognosis of Crohn's Disease in Korean Patients Showing Proximal Small Bowel Involvement: Results from the CONNECT Study.

Kim OZ, Han DS, Park CH, Eun CS, Kim YS, Kim YH, Cheon JH, Ye BD, Kim JS.

Gut Liver. 2018 Jan 15;12(1):67-72. doi: 10.5009/gnl16500.

33.

Secure searching of biomarkers through hybrid homomorphic encryption scheme.

Kim M, Song Y, Cheon JH.

BMC Med Genomics. 2017 Jul 26;10(Suppl 2):42. doi: 10.1186/s12920-017-0280-3.

34.

Intramuscular Hematoma Following Radial Extracorporeal Shockwave Therapy for Chronic Neurogenic Heterotopic Ossification: A Case Report.

Kim H, Cheon JH, Lee DY, Cheon JH, Cho YK, Lee SH, Kang EY.

Ann Rehabil Med. 2017 Jun;41(3):498-504. doi: 10.5535/arm.2017.41.3.498. Epub 2017 Jun 29.

35.

Optimal diagnosis and disease activity monitoring of intestinal Behçet's disease.

Lee HJ, Cheon JH.

Intest Res. 2017 Jul;15(3):311-317. doi: 10.5217/ir.2017.15.3.311. Epub 2017 Jun 12. Review.

36.

Could adalimumab be used safely and effectively in intestinal Behçet's disease refractory to conventional therapy?

Park J, Cheon JH.

Intest Res. 2017 Jul;15(3):263-265. doi: 10.5217/ir.2017.15.3.263. Epub 2017 Jun 12. No abstract available.

37.

The JAK2 inhibitors CEP-33779 and NVP-BSK805 have high P-gp inhibitory activity and sensitize drug-resistant cancer cells to vincristine.

Cheon JH, Kim KS, Yadav DK, Kim M, Kim HS, Yoon S.

Biochem Biophys Res Commun. 2017 Sep 2;490(4):1176-1182. doi: 10.1016/j.bbrc.2017.06.178. Epub 2017 Jun 29.

PMID:
28669723
38.

Rediscover the clinical value of small intestinal bacterial overgrowth in patients with intestinal Behçet's disease.

Jo JH, Park SJ, Cheon JH, Kim TI, Kim WH.

J Gastroenterol Hepatol. 2018 Feb;33(2):375-379. doi: 10.1111/jgh.13855.

PMID:
28666309
39.

Incidence and Clinical Outcomes of Inflammatory Bowel Disease in South Korea, 2011-2014: A Nationwide Population-Based Study.

Jung YS, Han M, Kim WH, Park S, Cheon JH.

Dig Dis Sci. 2017 Aug;62(8):2102-2112. doi: 10.1007/s10620-017-4640-9. Epub 2017 Jun 7.

PMID:
28593437
40.

The Effects of Physical Activity and Body Fat Mass on Colorectal Polyp Recurrence in Patients with Previous Colorectal Cancer.

Park J, Kim JH, Lee HJ, Park SJ, Hong SP, Cheon JH, Kim WH, Park JS, Jeon JY, Kim TI.

Cancer Prev Res (Phila). 2017 Aug;10(8):478-484. doi: 10.1158/1940-6207.CAPR-17-0065. Epub 2017 Jun 5.

41.

Hataedock treatment has preventive therapeutic effects for atopic dermatitis through skin barrier protection in Dermatophagoides farinae-induced NC/Nga mice.

Cha HY, Ahn SH, Cheon JH, Park SY, Kim K.

J Ethnopharmacol. 2017 Jul 12;206:327-336. doi: 10.1016/j.jep.2017.06.001. Epub 2017 Jun 3.

PMID:
28583294
42.

Proteomic Analysis of Serum Amyloid A as a Potential Marker in Intestinal Behçet's Disease.

Lee HJ, Kim JH, Kim SW, Joo HA, Lee HW, Kim YS, Park SJ, Hong SP, Kim TI, Kim WH, Kim YH, Cheon JH.

Dig Dis Sci. 2017 Aug;62(8):1953-1962. doi: 10.1007/s10620-017-4606-y. Epub 2017 May 18.

PMID:
28523576
43.

Combination of corticosteroids and 5-aminosalicylates or corticosteroids alone for patients with moderate-severe active ulcerative colitis: A global survey of physicians' practice.

Ben-Horin S, Andrews JM, Katsanos KH, Rieder F, Steinwurz F, Karmiris K, Cheon JH, Moran GW, Cesarini M, Stone CD, Schwartz D, Protic M, Roblin X, Roda G, Chen MH, Har-Noy O, Bernstein CN.

World J Gastroenterol. 2017 Apr 28;23(16):2995-3002. doi: 10.3748/wjg.v23.i16.2995.

44.

Postoperative adjuvant chemotherapy is associated with a lower incidence of colorectal adenomas in patients with previous colorectal cancer.

Lee HS, Kim SB, Lee HJ, Park SJ, Hong SP, Cheon JH, Kim WH, Kim TI.

Gastrointest Endosc. 2018 Mar;87(3):688-694.e2. doi: 10.1016/j.gie.2017.04.004. Epub 2017 Apr 18.

PMID:
28431950
45.

Development of a Novel Predictive Model for the Clinical Course of Crohn's Disease: Results from the CONNECT Study.

Park Y, Cheon JH, Park YL, Ye BD, Kim YS, Han DS, Kim JS, Hong SN, Kim YH, Jeon SR, Kim WH; IBD Study Group of the Korean Association for the Study of Intestinal Diseases (KASID).

Inflamm Bowel Dis. 2017 Jul;23(7):1071-1079. doi: 10.1097/MIB.0000000000001106.

PMID:
28410345
46.

Interleukin-33 regulates intestinal inflammation by modulating macrophages in inflammatory bowel disease.

Seo DH, Che X, Kwak MS, Kim S, Kim JH, Ma HW, Kim DH, Kim TI, Kim WH, Kim SW, Cheon JH.

Sci Rep. 2017 Apr 12;7(1):851. doi: 10.1038/s41598-017-00840-2.

47.

Cancer Risk in the Early Stages of Inflammatory Bowel Disease in Korean Patients: A Nationwide Population-based Study.

Jung YS, Han M, Park S, Kim WH, Cheon JH.

J Crohns Colitis. 2017 Aug 1;11(8):954-962. doi: 10.1093/ecco-jcc/jjx040.

PMID:
28333358
48.

Pathogenesis of Inflammatory Bowel Disease and Recent Advances in Biologic Therapies.

Kim DH, Cheon JH.

Immune Netw. 2017 Feb;17(1):25-40. doi: 10.4110/in.2017.17.1.25. Epub 2017 Feb 23. Review.

49.

Influence of age at diagnosis on the clinical characteristics of Crohn's disease in Korea: Results from the CONNECT study.

Hwang SW, Kim JH, Im JP, Ye BD, Koo HS, Huh KC, Cheon JH, Kim YS, Kim YH, Han DS, Kim WH, Kim JS; Crohn's disease clinical network and cohort (CONNECT) study.

J Gastroenterol Hepatol. 2017 Oct;32(10):1716-1722. doi: 10.1111/jgh.13775.

PMID:
28251684
50.

The effect of metformin on the recurrence of colorectal adenoma in diabetic patients with previous colorectal adenoma.

Han MS, Lee HJ, Park SJ, Hong SP, Cheon JH, Kim WH, Kim TI.

Int J Colorectal Dis. 2017 Aug;32(8):1223-1226. doi: 10.1007/s00384-017-2782-z. Epub 2017 Feb 16.

PMID:
28210856

Supplemental Content

Loading ...
Support Center